DR. EFREN J

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 742896
                    [Title] => First-line treatment for advanced ovarian cancer
                    [Summary] => 
Pharmaceutical company Roche recently launched an important milestone making its targeted therapy bevacizumab available for a disease where few treatment advances have been seen in over two decades.
                    [DatePublished] => 2011-11-01 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

abtest

First-line treatment for advanced ovarian cancer

November 1, 2011 - 12:00am

Pharmaceutical company Roche recently launched an important milestone making its targeted therapy bevacizumab available for a disease where few treatment advances have been seen in over two decades.

Health And Family